Research location
Southampton
Hants, United Kingdom
Advertisement
Research activity in Southampton
Hants, United KingdomCureCurrent currently publishes aggregate city-level research activity for this location: 10 trials and 10 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Southampton
10 linked trials · page 1 of 1A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes PatientsNCT02616666 · 2016-08-25 · 1 site observation
COMPLETED
A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) ParticipantsNCT01900652 · 2013-08-01 · 1 site observation
COMPLETED
An Extension Study in Participants With Moderate to Severe Rheumatoid ArthritisNCT01885078 · 2013-06-27 · 1 site observation
COMPLETED
A Study in Participants With Moderate to Severe Rheumatoid ArthritisNCT01711359 · 2012-11-01 · 1 site observation
COMPLETED
Effects of Repeated Attachment Security Priming on Depressed Mood: a Clinical StudyNCT01694030 · 2012-11-01 · 1 site observation
UNKNOWN
A Study in Moderate to Severe Rheumatoid ArthritisNCT01710358 · 2012-10-01 · 1 site observation
COMPLETED
Safety and Efficacy of Talactoferrin in Previously Treated Patients With Non-small Cell Lung CancerNCT00707304 · 2008-11-01 · 1 site observation
COMPLETED
Effect of LY450139 on the Long Term Progression of Alzheimer's DiseaseNCT00594568 · 2008-03-01 · 1 site observation
COMPLETED
Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC)NCT00494026 · 2007-09-01 · 1 site observation
TERMINATED
The Clinical Effectiveness of Static Resting Splints in Early Rheumatoid ArthritisNCT00474877 · 2001-10-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.